DBV Technologies Stock (NASDAQ: DBVT) stock price, news, charts, stock research, profile.
Open | $0.732 |
Close | - |
Volume / Avg. | 11.211K / 64.165K |
Day Range | 0.720 - 0.760 |
52 Wk Range | 0.650 - 2.370 |
Market Cap | $145.776M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | - |
Days to Cover | 14.11 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of DBV Technologies (NASDAQ: DBVT) through any online brokerage.
Other companies in DBV Technologies’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Molecular Partners (NASDAQ:MOLN), Vincerx Pharma (NASDAQ:VINC), CytomX Therapeutics (NASDAQ:CTMX) and Galectin Therapeutics (NASDAQ:GALT).
The latest price target for DBV Technologies (NASDAQ: DBVT) was reported by HC Wainwright & Co. on Wednesday, February 21, 2024. The analyst firm set a price target for 10.00 expecting DBVT to rise to within 12 months (a possible 1219.96% upside). 9 analyst firms have reported ratings in the last year.
The stock price for DBV Technologies (NASDAQ: DBVT) is $0.7576 last updated March 27, 2024 at 7:28 PM EDT.
There are no upcoming dividends for DBV Technologies.
DBV Technologies’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for DBV Technologies.
DBV Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.